PINTnet: construction of condition-specific pathway interaction network by computing shortest paths on weighted PPI

BackgroundIdentifying perturbed pathways in a given condition is crucial in understanding biological phenomena. In addition to identifying perturbed pathways individually, pathway analysis should consider interactions among pathways. Currently available pathway interaction prediction methods are based on the existence of overlapping genes between pathways, protein-protein interaction (PPI) or functional similarities. However, these approaches just consider the pathways as a set of genes, thus they do not take account of topological features. In addition, most of the existing approaches do not handle the explicit gene expression quantity information that is routinely measured by RNA-sequecing.ResultsTo overcome these technical issues, we developed a new pathway interaction network construction method using PPI, closeness centrality and shortest paths. We tested our approach on three different high-throughput RNA-seq data sets: pregnant mice data to reveal the role of serotonin on beta cell mass, bone-metastatic breast cancer data and autoimmune thyroiditis data to study the role of IFN- α. Our approach successfully identified the pathways reported in the original papers. For the pathways that are not directly mentioned in the original papers, we were able to find evidences of pathway interactions by the literature search. Our method outperformed two existing approaches, overlapping gene-based approach (OGB) and protein-protein interaction-based approach (PB), in experiments with the three data sets.ConclusionOur results show that PINTnet successfully identified condition-specific perturbed pathways and the interactions between the pathways. We believe that our method will be very useful in characterizing biological mechanisms at the pathway level. PINTnet is available at http://biohealth.snu.ac.kr/software/PINTnet/.

[1]  Ueng-Cheng Yang,et al.  Discovering pathway cross-talks based on functional relations between pathways , 2012, BMC Genomics.

[2]  M. Padrines,et al.  Proteoglycans on bone tumor development. , 2010, Drug discovery today.

[3]  T. Guise,et al.  The role of TGF-β in bone metastasis: novel therapeutic perspectives. , 2012, BoneKEy reports.

[4]  K. Yamamoto,et al.  Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Couchman,et al.  Wnt Signaling Cascades and the Roles of Syndecan Proteoglycans , 2015, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[6]  J. Nielsen,et al.  Effects of growth hormone, prolactin, and placental lactogen on insulin content and release, and deoxyribonucleic acid synthesis in cultured pancreatic islets. , 1982, Endocrinology.

[7]  Hans Clevers,et al.  Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields , 2012, Science Signaling.

[8]  D. Harrison,et al.  The JAK/STAT signaling pathway , 2004, Journal of Cell Science.

[9]  O. Hegre,et al.  Prolactin (in vitro) decreases the glucose stimulation threshold, enhances insulin secretion, and increases dye coupling among islet B cells. , 1987, Endocrinology.

[10]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[11]  G. Morahan,et al.  Faculty Opinions recommendation of Serotonin regulates pancreatic beta cell mass during pregnancy. , 2010 .

[12]  A. Swaroop,et al.  Next-generation sequencing facilitates quantitative analysis of wild-type and Nrl−/− retinal transcriptomes , 2011, Molecular vision.

[13]  Y. Tomer,et al.  IFN-α Mediates the Development of Autoimmunity both by Direct Tissue Toxicity and through Immune Cell Recruitment Mechanisms , 2011, The Journal of Immunology.

[14]  L. Aerts,et al.  A MORPHOLOGICAL STUDY OF THE ENDOCRINE PANCREAS IN HUMAN PREGNANCY , 1978, British journal of obstetrics and gynaecology.

[15]  A. Cress,et al.  Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain , 2011, Molecular pain.

[16]  P. Chanson,et al.  New insights in prolactin: pathological implications , 2015, Nature Reviews Endocrinology.

[17]  J. Ashwell,et al.  Cross‐Talk between the T Cell Antigen Receptor and the Glucocorticoid Receptor Regulates Thymocyte Development , 1996, Stem cells.

[18]  Hwa-Yong Lee,et al.  Blockade of Wnt/β-catenin signaling suppresses breast cancer metastasis by inhibiting CSC-like phenotype , 2015, Scientific Reports.

[19]  Jeff S. Jasper,et al.  ABL kinases promote breast cancer osteolytic metastasis by modulating tumor-bone interactions through TAZ and STAT5 signaling , 2016, Science Signaling.

[20]  Hai-Gwo Hwu,et al.  Methylenetetrahydrofolate reductase (MTHFR) genetic polymorphisms and psychiatric disorders: a HuGE review. , 2006, American journal of epidemiology.

[21]  Alfonso Valencia,et al.  EnrichNet: network-based gene set enrichment analysis , 2012, Bioinform..

[22]  Y. Shoenfeld,et al.  Toll-like Receptors and their Role in the Development of Autoimmune Diseases , 2004, Autoimmunity.

[23]  Pankaj Agarwal,et al.  A global pathway crosstalk network , 2008, Bioinform..

[24]  O. Kretz,et al.  MOF maintains transcriptional programs regulating cellular stress response , 2015, Oncogene.

[25]  W. Han,et al.  Protein interaction network (PIN)-based breast cancer subsystem identification and activation measurement for prognostic modeling. , 2016, Methods.

[26]  Hiroyuki Ogata,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..

[27]  Xiao-Fan Wang,et al.  Signaling cross-talk between TGF-β/BMP and other pathways , 2009, Cell Research.

[28]  S. Stock,et al.  Regulation of Breast Cancer-induced Bone Lesions by β-Catenin Protein Signaling* , 2011, The Journal of Biological Chemistry.

[29]  Sangsoo Kim,et al.  GSA-SNP: a general approach for gene set analysis of polymorphisms , 2010, Nucleic Acids Res..

[30]  J. Parsons,et al.  Adaptation of islets of Langerhans to pregnancy: increased islet cell proliferation and insulin secretion correlates with the onset of placental lactogen secretion. , 1992, Endocrinology.

[31]  Shao Li,et al.  Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network , 2010, BMC Bioinformatics.

[32]  Robert A. Weinberg,et al.  Ras oncogenes: split personalities , 2008, Nature Reviews Molecular Cell Biology.

[33]  Tzong-Yi Lee,et al.  GPMiner: an integrated system for mining combinatorial cis-regulatory elements in mammalian gene group , 2012, BMC Genomics.

[34]  D. Pan,et al.  The hippo signaling pathway in development and cancer. , 2010, Developmental cell.

[35]  Georg Schett,et al.  Activation of p38 MAPK is a key step in tumor necrosis factor-mediated inflammatory bone destruction. , 2006, Arthritis and rheumatism.

[36]  Su He Wang,et al.  The role of apoptosis in thyroid autoimmunity. , 2007, Thyroid : official journal of the American Thyroid Association.

[37]  Martin Krzywinski,et al.  Points of Significance: Logistic regression , 2016, Nature Methods.

[38]  Mirko Francesconi,et al.  Reconstructing networks of pathways via significance analysis of their intersections , 2008, BMC Bioinformatics.

[39]  M. Tsujimoto,et al.  Activation of p38 mitogen‐activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor , 2000, FEBS letters.

[40]  Nobue Itasaki,et al.  Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[41]  M. Feldmann,et al.  T cell activation and antigen presentation in human thyroid autoimmunity. , 1992, Journal of autoimmunity.

[42]  M. Stephens,et al.  RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. , 2008, Genome research.

[43]  Michael Bader,et al.  Intracellular Serotonin Modulates Insulin Secretion from Pancreatic β-Cells by Protein Serotonylation , 2009, PLoS biology.

[44]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Joaquín Dopazo,et al.  Gene set-based analysis of polymorphisms: finding pathways or biological processes associated to traits in genome-wide association studies , 2009, Nucleic Acids Res..

[46]  Léon Personnaz,et al.  Enrichment or depletion of a GO category within a class of genes: which test? , 2007, Bioinform..

[47]  Per Karlsson,et al.  Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome , 2013, BMC Cancer.

[48]  S. Merrill,et al.  Thyroid autoimmunity as a window to autoimmunity: An explanation for sex differences in the prevalence of thyroid autoimmunity. , 2015, Journal of theoretical biology.

[49]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[50]  C. Mason,et al.  Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data , 2013, Genome Biology.

[51]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[52]  Renato V Iozzo,et al.  Proteoglycans in cancer biology, tumour microenvironment and angiogenesis , 2011, Journal of cellular and molecular medicine.

[53]  J. Ussher,et al.  Constructions of sex and intimacy after cancer: Q methodology study of people with cancer, their partners, and health professionals , 2013, BMC Cancer.

[54]  S. Bicciato,et al.  The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer Cells , 2011, Cell.

[55]  J. Cross,et al.  Prolactin receptor is required for normal glucose homeostasis and modulation of beta-cell mass during pregnancy. , 2009, Endocrinology.

[56]  B. Kholodenko,et al.  Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. , 2012, Biochemical Society transactions.

[57]  Jenny J. Li,et al.  A Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue Sarcomas , 2015, Front. Oncol..

[58]  Ann Wu,et al.  A preconditioning nerve lesion inhibits mechanical pain hypersensitivity following subsequent neuropathic injury , 2011, Molecular pain.

[59]  Michael R. Kosorok,et al.  Detection of gene pathways with predictive power for breast cancer prognosis , 2010, BMC Bioinformatics.

[60]  Yves Moreau,et al.  The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models , 2013, Genome Biology.

[61]  S. Drăghici,et al.  Analysis and correction of crosstalk effects in pathway analysis , 2013, Genome research.

[62]  F. Jirik,et al.  Selumetinib produces a central core of apoptosis in breast cancer bone metastases in mice , 2014, Oncoscience.

[63]  Pradip De,et al.  Wnt signaling in triple negative breast cancer is associated with metastasis , 2013, BMC Cancer.

[64]  T. Guise Breast Cancer Bone Metastases: It’s All about the Neighborhood , 2013, Cell.

[65]  K. Kaestner,et al.  Expansion of β-cell mass in response to pregnancy , 2010, Trends in Endocrinology & Metabolism.

[66]  Koichi Suzuki,et al.  Innate immune activation and thyroid autoimmunity. , 2011, The Journal of clinical endocrinology and metabolism.

[67]  T. M. Murali,et al.  Xtalk: a path-based approach for identifying crosstalk between signaling pathways , 2015, Bioinform..

[68]  B. McManus,et al.  Variation in RNA-Seq Transcriptome Profiles of Peripheral Whole Blood from Healthy Individuals with and without Globin Depletion , 2014, PloS one.

[69]  P. Kelly,et al.  Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. , 1998, Endocrine reviews.

[70]  Reddanna Pallu,et al.  Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells , 2013, Front. Oncol..